Clinical trial
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
NCT03800979 is registered in ClinicalTrials.gov with Institute of Dermatology, Thailand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
- Lead sponsor
- Institute of Dermatology, Thailand
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 12, 2019
- Completion date
- January 30, 2021
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.